세계의 관상동맥우회술 시장 보고서(2025년)
Coronary Artery Bypass Graft Global Market Report 2025
상품코드 : 1824366
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

관상동맥우회술 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 CAGR 9.0%로 192억 4,000만 달러로 성장할 것으로 예상됩니다. 예측 기간의 성장은 외래수술센터(ASCS)의 성장, 디지털 건강 통합, 원격 의료 성장, 원격 환자 모니터링 장비 및 환자 중심 접근 방식에 기인할 수 있습니다. 예측기간의 주요 동향으로는 수술기술의 진보, 협동연구, 수술에 있어서의 로봇, 생분해성 임플란트, 진단 목적의 인공지능, 외과의사를 위한 가상 현실 훈련 등이 있습니다.

향후 5년간의 성장률 9.0%라고 하는 예측은 전회 예측으로부터 0.2%의 소폭 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세 장벽은 스위스와 아일랜드에서 공급되는 낮은 침습 CABG 안정화 시스템과 이식 재료의 비용을 증가시켜 수술 대기 시간을 늘리고 심장 수술 비용을 상승시켜 미국 시장을 방해할 것으로 예측됩니다. 또한 상호관세와 무역마찰이나 무역제한의 격화에 의한 세계경제나 무역에 대한 악영향에 의해 그 영향은 보다 광범위하게 미칠 것으로 예측됩니다.

예측되는 심혈관 질환의 유병률의 상승은 향후 관상동맥우회술 시장의 확대를 추진할 것입니다. 심혈관 질환(CVD)에는 다양한 심장과 혈관 질환이 포함됩니다. 심장 발작의 위험을 줄이기 위해, 관상동맥우회술(CABG)는 심장의 폐색 동맥과 부분적으로 폐색된 동맥 주위에 혈류를 위한 새로운 경로를 만듭니다. 영국 대학 출판사인 Oxford University Press가 발행한 잡지에 따르면 말초 동맥 질환을 앓고 있는 사람의 비율은 2045년까지 50% 증가할 것으로 예측됩니다. 그 결과, 심혈관 질환의 유병률 증가는 관상동맥우회술 시장의 성장을 가속합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

SHW
영문 목차

영문목차

A coronary artery bypass graft (CABG) is a surgical intervention designed to treat coronary artery disease. This procedure is performed when the coronary arteries, responsible for delivering blood to the heart, become narrowed or blocked, potentially leading to angina or a heart attack.

The primary procedures for coronary artery bypass grafting include single coronary artery bypass graft (CABG) surgery, double coronary artery bypass graft (CABG) surgery, triple coronary artery bypass graft (CABG) surgery, quadruple coronary artery bypass graft (CABG) surgery, and others. Single coronary artery bypass graft (CABG) surgery is a surgical intervention utilized for the management of coronary heart disease. Both off-pump and on-pump methods are employed by various healthcare facilities, including hospitals, cardiology clinics, research institutes, and other end-users.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The coronary artery bypass graft research report is one of a series of new reports from The Business Research Company that provides coronary artery bypass graft market statistics, including the coronary artery bypass graft industry's global market size, regional shares, competitors with coronary artery bypass graft market share, detailed coronary artery bypass graft market segments, market trends and opportunities, and any further data you may need to thrive in the coronary artery bypass graft industry. This coronary artery bypass graft market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The coronary artery bypass graft market size has grown strongly in recent years. It will grow from $12.58 billion in 2024 to $13.61 billion in 2025 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to aging population, healthcare infrastructure growth, rising cardiovascular diseases, awareness campaigns, insurance coverage.

The coronary artery bypass graft market size is expected to see strong growth in the next few years. It will grow to $19.24 billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to ambulatory surgery centers (ASCS) growth, digital health integration, telemedicine growth, remote patient monitoring devices, patient-centric approaches. Major trends in the forecast period include advancements in surgical techniques, collaborative research, robotics in surgery, biodegradable implants, ai for diagnostic purposes, virtual reality training for surgeons.

The forecast of 9.0% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. market by increasing the cost of minimally invasive CABG stabilization systems and graft materials sourced from Switzerland and Ireland, thereby prolonging surgical wait times and elevating cardiac surgery expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated rise in the prevalence of cardiovascular diseases is poised to propel the expansion of the coronary artery bypass graft market in the future. Cardiovascular disease (CVD) encompasses various heart and blood vessel ailments. To reduce the risk of heart attacks, a coronary artery bypass graft (CABG) creates a new pathway for blood flow around blocked or partially blocked arteries in the heart. As per a journal published by Oxford University Press, a UK-based university press, the percentage of people affected by peripheral artery diseases is expected to increase by 50% by 2045. Consequently, the increased prevalence of cardiovascular diseases drives the growth of the coronary artery bypass graft market.

The growing geriatric population is anticipated to be a driving force behind the expansion of the coronary artery bypass graft market. The geriatric population consists of individuals who are elderly or of advanced age. Coronary artery bypass graft (CABG) surgery addresses severe coronary artery disease (CAD) in the geriatric population by bypassing blocked or narrowed arteries with healthy blood vessels. This restores blood flow to the heart muscle and improves its function. According to the World Health Organization, globally, one in six people will be 60 or older by 2030, and the number of individuals in this age group is expected to double to 2.1 billion by 2050. Additionally, a report by the UK Parliament's House of Commons Library indicates that by 2043, seniors will make up 24% of the total population in the UK, reaching 17.4 million people. Therefore, the increasing geriatric population is fostering the growth of the coronary artery bypass graft market.

Strategic collaboration emerges as a prominent trend gaining traction in the coronary artery bypass graft market, with major companies focusing on partnerships to fortify their positions and gain a competitive edge. For example, Medtronic plc, a US-based medical device company, collaborated with CathWorks, an Israel-based medical equipment manufacturer. The collaboration involves Medtronic investing a maximum of $75 million in CathWorks and jointly promoting CathWorks' FFRangio System in the United States, Japan, and Europe. Another instance is the collaboration between Etiometry, a US-based clinical decision-support software provider, and Terumo Cardiovascular, a US-based manufacturer of medical devices for cardiac and vascular surgery. This collaboration aims to provide advanced clinical decision support for adult cardiac surgery patients during and after their post-surgical recovery.

Major companies in the coronary artery bypass graft market are focusing on innovative advancements like surgical robotic systems to enhance precision and minimize invasiveness, thereby improving patient outcomes. They are also exploring AI and minimally invasive techniques to optimize procedures and reduce recovery times. A surgical robotic system is a high-tech platform that assists surgeons in conducting minimally invasive procedures with greater precision and visualization. It typically consists of robotic arms, advanced imaging, and a console for the surgeon to control the instruments. For example, in October 2023, SS Innovations International Inc., a US-based manufacturer of surgical and medical instruments, launched the SSi Mantra surgical robotic system. This system is designed to offer advanced, cost-effective robotic surgery solutions across various specialties, including cardiac procedures. Its key advantages include improved surgical precision, shorter recovery times through minimally invasive techniques, and the integration of machine learning to enhance safety and efficiency during operations.

In August 2022, Medtronic plc, a US-based medical device company, completed the acquisition of Affera Inc. for an undisclosed amount. This acquisition enhances Medtronic's cardiac ablation lineup by introducing a cardiac mapping and navigation platform, incorporating a distinctive diagnostic tool, focused pulsed field technology, and a radiofrequency ablation solution. Affera Inc. is a US-based medical technology company specializing in coronary artery bypass graft (CABG) procedures.

Major companies operating in the coronary artery bypass graft market include CryoLife Inc., Johnson & Johnson Co, Abbott Laboratories, Medtronic plc, Stryker Corporation, Northwell Health, Boston Scientific Corporation, Penn Medicine, Geisinger Health System Co, Terumo Corporation, Edwards Lifesciences Corporation, Main Line Health Inc., Getinge AB, Teleflex Incorporated, W. L. Gore & Associates Inc., Guidant Group, LivaNova PLC, AtriCure Inc., Peter Surgical, Cardiva Medical Inc., Genesee Biomedical Inc., Dextera Surgical Inc., Cardica Inc., Maquet Holding B.V. & Co.KG, Vitalitec International Medizintechnik GmbH, Hancock Jaffe Laboratories.

North America was the largest region in the coronary artery bypass graft market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coronary artery bypass graft market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the coronary artery bypass graft market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The coronary artery bypass graft market consists of revenues earned by entities by providing services such as bypass grafts, peripheral vascular grafts, hemodialysis access grafts, and endovascular stent grafts. The market value includes the value of related goods sold by the service provider or included within the service offering. The coronary artery bypass graft market also includes sales of forceps, vascular forceps, grasping forceps, needle holders, scissors, and clamps. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Coronary Artery Bypass Graft Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on coronary artery bypass graft market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for coronary artery bypass graft ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The coronary artery bypass graft market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Coronary Artery Bypass Graft Market Characteristics

3. Coronary Artery Bypass Graft Market Trends And Strategies

4. Coronary Artery Bypass Graft Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Coronary Artery Bypass Graft Growth Analysis And Strategic Analysis Framework

6. Coronary Artery Bypass Graft Market Segmentation

7. Coronary Artery Bypass Graft Market Regional And Country Analysis

8. Asia-Pacific Coronary Artery Bypass Graft Market

9. China Coronary Artery Bypass Graft Market

10. India Coronary Artery Bypass Graft Market

11. Japan Coronary Artery Bypass Graft Market

12. Australia Coronary Artery Bypass Graft Market

13. Indonesia Coronary Artery Bypass Graft Market

14. South Korea Coronary Artery Bypass Graft Market

15. Western Europe Coronary Artery Bypass Graft Market

16. UK Coronary Artery Bypass Graft Market

17. Germany Coronary Artery Bypass Graft Market

18. France Coronary Artery Bypass Graft Market

19. Italy Coronary Artery Bypass Graft Market

20. Spain Coronary Artery Bypass Graft Market

21. Eastern Europe Coronary Artery Bypass Graft Market

22. Russia Coronary Artery Bypass Graft Market

23. North America Coronary Artery Bypass Graft Market

24. USA Coronary Artery Bypass Graft Market

25. Canada Coronary Artery Bypass Graft Market

26. South America Coronary Artery Bypass Graft Market

27. Brazil Coronary Artery Bypass Graft Market

28. Middle East Coronary Artery Bypass Graft Market

29. Africa Coronary Artery Bypass Graft Market

30. Coronary Artery Bypass Graft Market Competitive Landscape And Company Profiles

31. Coronary Artery Bypass Graft Market Other Major And Innovative Companies

32. Global Coronary Artery Bypass Graft Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Coronary Artery Bypass Graft Market

34. Recent Developments In The Coronary Artery Bypass Graft Market

35. Coronary Artery Bypass Graft Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기